{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:43:18Z","timestamp":1772174598793,"version":"3.50.1"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.neubiorev.2016.10.017","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T19:33:23Z","timestamp":1476992003000},"page":"657-670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Pretreatment and prophylaxis against nerve agent poisoning: Are undesirable behavioral side effects unavoidable?"],"prefix":"10.1016","volume":"71","author":[{"given":"Trond","family":"Myhrer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e5l","family":"Aas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2016.10.017_bib0005","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1017\/S1049023X00001072","article-title":"Future considerations for the medical management of nerve agent intoxication","volume":"18","author":"Aas","year":"2003","journal-title":"Prehosp. Disast. Med."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/toxsci\/60.2.305","article-title":"Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide DEET, and permithrin, alone and in combination","volume":"60","author":"Abou-Donia","year":"2001","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0015","doi-asserted-by":"crossref","first-page":"13220","DOI":"10.1073\/pnas.0605370103","article-title":"Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents","volume":"103","author":"Albuquerque","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0020","first-page":"121","article-title":"Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase","volume":"43","author":"Allon","year":"1998","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbr.2009.05.002","article-title":"Gulf war illness: effects of repeated stress and pyridostigmine treatment on blood-brain barrier permeability and cholinesterase activity in rat brain","volume":"203","author":"Amourette","year":"2009","journal-title":"Behav. Brain. Res."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0030","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF00636797","article-title":"Pharmacokinetics and oral bioavailability of pyridostigmine in man","volume":"18","author":"Aquilonius","year":"1980","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0035","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/milmed\/157.4.210","article-title":"Effects of heat-exercise stress, NBC clothing, and pyridostigmine treatment on psychomotor and subjective measures of performance","volume":"157","author":"Arad","year":"1992","journal-title":"Mil. Med."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0040","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0006-291X(92)90649-6","article-title":"Mechanism of inhibition of cholinesterase by HUP A","volume":"30","author":"Ashani","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0045","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.2174\/092986709788803088","article-title":"Chemical aspects of pharmacological prophylaxis against nerve agent poisoning","volume":"16","author":"Bajgar","year":"2009","journal-title":"Cur. Med. Chem."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0050","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bbr.2008.08.032","article-title":"Repeated stress in combination with pyridostigmine. Part II: changes in cerebral gene expression","volume":"197","author":"Barbier","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/brain\/awm299","article-title":"Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer\u2019s disease and health","volume":"131","author":"Bentley","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0060","series-title":"Conflict, Arousal and Curiosity","author":"Berlyne","year":"1960"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0065","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0166-4328(98)00041-2","article-title":"Anxiety and cardiovascular reactivity: the basal forebrain cholinergic link","volume":"94","author":"Berntson","year":"1998","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/096032718500400310","article-title":"Studies on the possible central and peripheral effects in man of a cholinesterase inhibitor (pyridostigmine)","volume":"4","author":"Borland","year":"1985","journal-title":"Hum. Toxicol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/milmed\/157.6.275","article-title":"A brief survey of chemical defense, crew rest, and heat stress\/physical training issues related to operation desert storm","volume":"157","author":"Caldwell","year":"1992","journal-title":"Mil. Med."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0080","first-page":"363","article-title":"In vitro and in vivo characterization of recombinant human butyrylcholinesterase (protexia\u2122) as a potential nerve agent bioscavenger","author":"Cerasoli","year":"2005","journal-title":"Chem. Bio. Int."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0085","first-page":"214","article-title":"Potentiation of pyridostigmine bromide toxicity in mice by selected adrenergic agents and caffeine","volume":"39","author":"Chaney","year":"1997","journal-title":"Vet. Hum. Toxicol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.etap.2011.10.002","article-title":"Minimum effective drug concentrations of a transdermal patch system containing procyclidine and physostigmine for prophylaxis against soman poisoning in rhesus monkeys","volume":"33","author":"Cho","year":"2012","journal-title":"Env. Toxicol. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0095","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.pbb.2005.04.006","article-title":"Effects of physostigmine and human butyrylcholinesterase on acoustic startle reflex and prepulse inhibition in C57BL\/6J mice","volume":"81","author":"Clark","year":"2005","journal-title":"Pharamacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0100","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/milmed\/157.5.250","article-title":"Chronic pyridostigmine bromide administration: side effects among soldiers working in a desert environment","volume":"157","author":"Cook","year":"1992","journal-title":"Mil. Med."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0105","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00213-002-1074-6","article-title":"Physiological and performance effects of pyridostigmine bromide in healthy volunteers: a dose-response study","volume":"162","author":"Cook","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1742-1241.2003.tb10467.x","article-title":"Galantamine: a review of its use in Alzheimer\u2019s disease and vascular dementia","volume":"57","author":"Corey-Bloom","year":"2003","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.2042-7158.1979.tb13504.x","article-title":"The protection of primates against soman poisoning by pretreatment with pyridostigmine","volume":"31","author":"Dirnhuber","year":"1979","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0120","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/phrs.1998.0361","article-title":"Effects of lesions of the substantia\/innominatal ventral pallidum, globus pallidus and medial septum on rats\u2019 performance in object recognition and radial-maze tasks: physostigmine and amphetamine treatments","volume":"38","author":"Ennaceur","year":"1998","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0125","unstructured":"FDA. (US Food and Drug Administration). Bioterrorism and drug preparedness., 2009. http:\/\/www.fda.gov\/drugs\/emergencypreparedness\/bioterrorismand drugpreparedness\/ucm130343.htm."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0130","first-page":"219","article-title":"Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man","volume":"50","author":"Freireich","year":"1966","journal-title":"Cancer Chemother. Rep."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0135","series-title":"Proceedings of the Meeting of NATO 004 Task Group on Prophylaxis and Therapy of Chemical Agents: 2-5 October 2000","first-page":"63","article-title":"The prophylactic antidote against nerve paralytic agents\u2014PANPAL","author":"Fusek","year":"2000"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0140","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.2042-7158.1998.tb03349.x","article-title":"Anti-nicotinic properties of anticholinergic antiparkinson drugs","volume":"50","author":"Gao","year":"1998","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/001872089003200106","article-title":"Effects of pyridostigmine bromide on in-flight aircrew performance","volume":"32","author":"Gawron","year":"1990","journal-title":"Hum. Factors"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0150","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0091-3057(95)91937-L","article-title":"Behavioral and pharmacological assessment of butyrylcholinesterase in rats","volume":"51","author":"Genovese","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0155","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1073\/pnas.0711986105","article-title":"Acetylcholinesterase inhibitors and gulf war illness","volume":"105","author":"Golomb","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/taap.2000.8906","article-title":"Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration","volume":"164","author":"Grauer","year":"2000","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0165","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0361-9230(97)00381-X","article-title":"The role of central cholinergic projections in cognition: implications of the effects of scopolamine on discrimination learning by monkeys","volume":"46","author":"Harder","year":"1998","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0170","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/01480548409042823","article-title":"Protection against lethal and behavioral effects of soman","volume":"7","author":"Harris","year":"1984","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1037\/0735-7044.118.1.79","article-title":"The effects of peripheral vagal nerve stimulation at a memory-modulating intensity on norepinephrine output in the basolateral amygdala","volume":"118","author":"Hassert","year":"2004","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0180","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.taap.2006.12.023","article-title":"The combination of donepezil and procyclidine protects against soman-induced seizures in rats","volume":"220","author":"Haug","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0185","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0091-3057(85)90423-X","article-title":"Effects of pesticides and drugs on working memory in rats: continuous delayed response","volume":"23","author":"Heise","year":"1985","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cbi.2012.10.015","article-title":"Assessing protection against OP pesticides and nerve agents provided by wild-type HuPON1 purified from Trichoplusia ni larvae or induced via adenoviral infection","volume":"203","author":"Hodgins","year":"2013","journal-title":"Chem.-Biol. Intact."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0195","series-title":"Gulf War and Health, Volume 8, Update of Health Effects of Serving in the Gulf War","author":"Institute of Medicine of the National Academies","year":"2010"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0200","first-page":"430","article-title":"The effects of repeated doses of 30mg pyridostigmine bromide on pilot performance in an A-4 flight simulator","volume":"61","author":"Israeli","year":"1990","journal-title":"Aviat. Space Environ. Med."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0205","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/096032719701601003","article-title":"Effects of Panpal pretreatment and antidotal treatment (HI-6 plus benactyzine) on respiratory and circulatory function in soman-poisoned rats","volume":"16","author":"Kassa","year":"1997","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0300-483X(97)00186-8","article-title":"The positive influence of a cholinergic-anticholinergic pretreatment and antidotal treatment on rats poisoned with supralethal doses of soman","volume":"128","author":"Kassa","year":"1998","journal-title":"Toxicology"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0300-483X(02)00219-6","article-title":"A comparison of the efficacy of pyridostigmine alone and the combination of pyridostigmine with anticholinergic drugs as pharmacological pretreatment of tabun-poisoned rats and mice","volume":"177","author":"Kassa","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0220","doi-asserted-by":"crossref","first-page":"101","DOI":"10.14712\/18059694.2019.15","article-title":"A comparison of neuroprotective efficacy of pharmacological pretreatment and antidotal treatment in soman-poisoned rats","volume":"46","author":"Kassa","year":"2003","journal-title":"Acta Med. (Hradec Kralove)"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0225","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.1991.03470050093029","article-title":"Pyridostigmine used as a nerve agent pretreatment under wartime conditions","volume":"266","author":"Keeler","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1382-6689(01)00096-5","article-title":"Effects of combinational prophylactics composed of physostigmine and procyclidine on soman-induced lethality, seizures and brain injuries","volume":"11","author":"Kim","year":"2002","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0235","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejphar.2005.09.052","article-title":"Protection by a transdermal patch containing physostigmine and procyclidine of soman poisoning in dogs","volume":"525","author":"Kim","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0240","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/BF01981500","article-title":"Evaluation of the toxicity, pathology, and treatment of cyclohexylmethylphosphonofluoriade (CMPF) poisoning in rhesus monkeys","volume":"66","author":"Koplovitz","year":"1992","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0245","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0272-0590(92)90201-R","article-title":"Reduction by pyridostigmine pretreatment of the efficacy of atropine and 2-PAM treatment of sarin and VX poisosning in rodents","volume":"18","author":"Koplovitz","year":"1992","journal-title":"Fund. Appl. Toxicol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0250","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0300-483X(02)00599-1","article-title":"Neuroprotective efficacy of pharmacological pretreatment and antidotal treatment in tabun-poisoned rats","volume":"185","author":"Krej\u010dov\u00e1","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0255","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tox.2006.08.036","article-title":"Polyethylene-glycol conjugated recombinant human acetylcholinesterase serves as an efficacious bioscavenger against soman intoxication","volume":"233","author":"Kronman","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0260","first-page":"759","article-title":"Heat stress, even extreme, does not induce penetration of pyridostigmine into the brain of guinea pigs","volume":"19","author":"Lallement","year":"1998","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0265","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuro.2015.05.003","article-title":"Is rivastigmine safe as pretreatment against nerve agent poisoning? A pharmacological, physiological and cognitive assessment in healthy young adult volunteers","volume":"49","author":"Lavon","year":"2015","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0270","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1016\/0272-0590(85)90132-0","article-title":"Treatment of poisoning by soman","volume":"5","author":"Leadbeater","year":"1985","journal-title":"Fund. Appl. Toxicol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0275","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cbi.2005.10.025","article-title":"Protection against soman or VX poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys","author":"Lenz","year":"2005","journal-title":"Chem. Biol. Int."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0280","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tox.2006.11.066","article-title":"Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review","volume":"233","author":"Lenz","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0285","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cbi.2010.05.014","article-title":"Butyrylcholinesterase as a therapeutic drug against percutaneous VX","volume":"187","author":"Lenz","year":"2010","journal-title":"Chem. Biol. Int."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0290","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archpsyc.1976.01770020061010","article-title":"Anxiety associated with exposure to organophosphate compounds","volume":"33","author":"Levin","year":"1976","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0295","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00204-006-0153-6","article-title":"Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning","volume":"81","author":"Levy","year":"2007","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0300","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00213-006-0556-3","article-title":"Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function with moderate effects on working memory, and spatial mapping","volume":"188","author":"Lindner","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0305","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0091-3057(91)90079-H","article-title":"Cholinolytic antagonism to the disruptive effects of oral low doses of pyridostigmine on simple discrimination performance in rats","volume":"40","author":"Liu","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0310","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0091-3057(92)90093-U","article-title":"Acute effects of oral low doses of pyridostigmine on simple visual discrimination and unconditioned consummatory acts in rats","volume":"41","author":"Liu","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0315","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0006-8993(92)90640-U","article-title":"Postinjury scopolamine administration in experimental traumatic brain injury","volume":"569","author":"Lyeth","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0320","series-title":"Handbook of Toxicology of Chemical Warfare Agents","first-page":"1107","article-title":"Catalytic bioscavengers: the new generation of bioscavenger-based medical countermeasures","author":"Masson","year":"2015"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0325","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0091-3057(98)00183-X","article-title":"Behavioral and immunological effects of exogenous butyrylcholinesterase in rhesus monkeys","volume":"62","author":"Matzke","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0330","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0091-3057(94)00372-P","article-title":"A study of the N-methyl-d-aspartate antagonistic properties of anticholinergic drugs","volume":"51","author":"McDonough","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0335","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0149-7634(96)00050-4","article-title":"Neuropharmacological mechanisms of nerve agent induced seizure and neuropathology","volume":"21","author":"McDonough","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0340","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1002\/jat.815","article-title":"Prophylaxis against organophosphate poisoning by sustained release of scopolamine and physostigmine","volume":"21","author":"Meshulam","year":"2001","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0345","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0091-3057(93)90472-6","article-title":"Efficacy of physostigmine as a pretreatment for organophosphate poisoning","volume":"44","author":"Miller","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0350","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0091-3057(79)90012-1","article-title":"Physostigmine: effects on fear or defense responses in the rat","volume":"11","author":"Mollenauer","year":"1979","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0355","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00213-002-1324-7","article-title":"Assessment of a combination of physostigmine and scopolamine as pretreatment against the behavioural effects of organophosphates in the common marmoset (Callithrix jacchus)","volume":"166","author":"Muggleton","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0360","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ntt.2012.02.002","article-title":"Characterization of human butyrylcholinesterase in rhesus monkeys: behavioral and physiological effects","volume":"34","author":"Myers","year":"2012","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0365","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ejphar.2003.09.041","article-title":"Cognitive side effects in rats caused by pharmacological agents used to prevent soman-induced lethality","volume":"483","author":"Myhrer","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0370","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.taap.2004.01.007","article-title":"Protection against soman-induced seizures: relationship among doses of prophylactics, soman, and adjuncts","volume":"196","author":"Myhrer","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0375","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.pbb.2008.02.022","article-title":"Antiparkinson drugs used as prophylactics for nerve agents: studies of cognitive side effects in rats","volume":"89","author":"Myhrer","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0380","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.pbb.2010.02.010","article-title":"Behavioral side effects in rats treated with acetylcholinesterase inhibitors suggested used as prophylactics against nerve agents","volume":"95","author":"Myhrer","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0385","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.neuro.2011.04.008","article-title":"Enhanced efficacy of anticonvulsants when combined with levetiracetam in soman-exposed rats","volume":"32","author":"Myhrer","year":"2011","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0390","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.tox.2013.08.005","article-title":"Two medical therapies very effective shortly after high levels of soman poisoning in rats, but only one with universal utility","volume":"314","author":"Myhrer","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0395","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejphar.2013.08.024","article-title":"Capacities of metabotropic glutamate modulators in counteracting soman-induced seizures in rats","volume":"718","author":"Myhrer","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0400","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.toxrep.2014.04.004","article-title":"Behavioral side effects of prophylactic therapies against soman-induced seizures and lethality in rats","volume":"1","author":"Myhrer","year":"2014","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0405","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0031-9384(88)90279-X","article-title":"The role of medial and lateral hippocampal perforant path lesions and object distinctiveness in rats\u2018 reaction to novelty","volume":"42","author":"Myhrer","year":"1988","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0410","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0031-9384(89)90151-0","article-title":"Exploratory behavior, reaction to novelty, and proactive memory in rats with temporo-entorhinal connections disrupted","volume":"45","author":"Myhrer","year":"1989","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0415","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0091-3057(98)00205-6","article-title":"Restored cognitive function in rats with combined denervations in the temporal region: neurochemical aspects","volume":"62","author":"Myhrer","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0420","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0165-0173(02)00268-0","article-title":"Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks","volume":"41","author":"Myhrer","year":"2003","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0425","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1212\/01.WNL.0000124519.85516.50","article-title":"The birth of nerve agent warfare\u2014lessons from Syed Abbas Foroutan","volume":"62","author":"Newmark","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0430","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0091-3057(92)90528-N","article-title":"Active avoidance behavior in guinea pigs: effects of physostigmine and scopolamine","volume":"42","author":"Philippens","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0435","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0091-3057(96)83115-7","article-title":"Side effects of physostigmine as a pretreatment in guinea pigs","volume":"55","author":"Philippens","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0440","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1037\/h0037651","article-title":"Fear reduction in the rat following central cholinergic blockade","volume":"86","author":"Plotnik","year":"1974","journal-title":"J. Comp. Physiol. Psychol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0445","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.neuro.2014.08.007","article-title":"Pathophysiological mechanisms underlying increased anxiety after soman exposure: reduced GABAergic inhibition in the basolateral amygdala","volume":"44","author":"Prager","year":"2014","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0450","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0006-2952(92)90028-H","article-title":"Protection against tabun toxicity in mice by prophylaxis with an enzyme hydrolyzing organophosphate esters","volume":"44","author":"Raveh","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0455","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/0006-2952(93)90228-O","article-title":"Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization","volume":"45","author":"Raveh","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0460","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/taap.1997.8160","article-title":"The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase","volume":"145","author":"Raveh","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0465","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0161-813X(02)00005-0","article-title":"Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction","volume":"23","author":"Raveh","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0470","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tox.2014.09.005","article-title":"Caramiphen edisylate: an optimal antidote against organophosphate poisoning","volume":"325","author":"Raveh","year":"2014","journal-title":"Toxicology"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0475","series-title":"Gulf War illness and the health of Gulf War veterans: Scientific findings and recommendations","author":"Research Advisory Committee on Gulf War Veterans\u2019 Illnesses","year":"2008"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0480","first-page":"303","article-title":"Rat models of ADHD","volume":"9","author":"Sagvolden","year":"2012","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0485","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF00634455","article-title":"Effects of physostimine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats","volume":"99","author":"Santucci","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0490","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cbi.2015.07.001","article-title":"Prophylaxis with human serum butyrylcholinesterase protects G\u00f6ttingen minipigs exposed to a lethal high-dose of sarin vapor","volume":"238","author":"Saxena","year":"2015","journal-title":"Chem. Biol. Int."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0495","series-title":"Chemical Warfare Agents: Toxicology and Treatment","first-page":"343","article-title":"Pretreatment for nerve agent poisoning","author":"Scott","year":"2007"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0500","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1124\/jpet.102.044818","article-title":"Delayed neurologic and behavioral effects of subtoxic doses of cholinesterase inhibitors","volume":"304","author":"Scremin","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0505","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0022-3565(24)37896-6","article-title":"Persistently exaggerated startle response in rats treated with pyridostigmine bromide","volume":"287","author":"Servatius","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0510","first-page":"656","article-title":"Survey of symptoms following intake of pyridostigmine during the Persian Gulf War","volume":"27","author":"Sharabi","year":"1991","journal-title":"Isr. J. Med. Sci."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0515","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0091-3057(91)90012-Q","article-title":"Acute effects of oral pyridostigmine bromide on conditioned operant performance in rats","volume":"38","author":"Shih","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0520","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0041-008X(03)00019-X","article-title":"Control of nerve agent-induced seizures is critical for neuroprotection and survival","volume":"188","author":"Shih","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0525","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0272-0590(86)90247-2","article-title":"Distribution and pharmacokinetics of physostigmine in rat after intramuscular administration","volume":"6","author":"Somani","year":"1986","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0530","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1254\/jjp.89.7","article-title":"Research and development of donepezil hydrochloride: a new type of acetylcholinesterase inhibitor","volume":"89","author":"Sugimoto","year":"2002","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0535","series-title":"The Pharmacological Basis of Therapeutics","first-page":"175","article-title":"Anticholinesterase agents","author":"Taylor","year":"2001"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0540","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11064-005-2614-3","article-title":"Peripheral ChE inhibition modulates brain monoamines levels and c-fos oncogene in mice subjected to a stress situation","volume":"30","author":"Taysse","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0545","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0161-813X(00)00015-2","article-title":"Effects of huperzine used as pre-treatment against soman-induced seizures","volume":"22","author":"Tonduli","year":"2001","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0550","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.toxlet.2011.02.007","article-title":"Recombinant paraoxonase 1 protects against sarin and soman toxicity following microinstillation inhalation exposure in guinea pigs","volume":"202","author":"Valiyaveettil","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0555","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0091-3057(00)00282-3","article-title":"The effects of pyridostigmine bromide and permethrin alone or on combination, on response acquisition in male and female rats","volume":"66","author":"Van Haaren","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0560","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0091-3057(00)00438-X","article-title":"The effects of pyridostigmine bromide on progressive ratio performance in male and female rats","volume":"68","author":"Van Haaren","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0565","first-page":"153","article-title":"Determination of drugs used as anti-Parkinson\u2018s disease drugs in urine and serum by capillary electrophoresis","volume":"5","author":"Vargas","year":"1998","journal-title":"J. Cap. Elec."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0570","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2125.1995.tb04410.x","article-title":"Pharmacokinetics of physostigmine in man following a single application of a transdermal system","volume":"39","author":"Walter","year":"1995","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0575","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0014-2999(00)00291-0","article-title":"Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats","volume":"398","author":"Wang","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0580","first-page":"37","article-title":"Effects of pyridostigmine bromide on physiological responses to heat, exercise, and hypohydration","volume":"63","author":"Wenger","year":"1992","journal-title":"Aviat. Space Environment. Med."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0585","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0161-813X(02)00082-7","article-title":"Physostigmine and hyoscine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea-pig","volume":"23","author":"Wetherell","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0590","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.2042-7158.1994.tb03260.x","article-title":"Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning","volume":"46","author":"Wetherell","year":"1994","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0595","first-page":"1054","article-title":"The effects of pyridostigmine bromide on visual performance","volume":"63","author":"Wiley","year":"1992","journal-title":"Aviat. Space Environ. Med."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0600","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0272-0590(84)90153-2","article-title":"Behavioral changes in the rat after low doses of cholinesterase inhibitors","volume":"4","author":"Wolthuis","year":"1984","journal-title":"Fund. Appl. Toxicol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0605","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00204-014-1204-z","article-title":"Efficacy of the rePON1 mutant llG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro","volume":"88","author":"Worek","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0610","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.toxlet.2014.02.010","article-title":"Effectiveness of a substituted \u00df-cyclodextrin to prevent cyclosarin toxicity in vivo","volume":"226","author":"Worek","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0615","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.toxlet.2014.09.003","article-title":"Post exposure treatment of VX poisoned guinea-pigs with the engineered phosphotriesterase mutant C23: A proof-of-concept study","volume":"231","author":"Worek","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neubiorev.2016.10.017_bib0620","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jns.2006.06.007","article-title":"Sarin experiences in Japan: acute toxicity and long-term effects","volume":"249","author":"Yanagisawa","year":"2006","journal-title":"J. Neurol. Sci."}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763416301920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763416301920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T18:44:37Z","timestamp":1749667477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763416301920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":124,"alternative-id":["S0149763416301920"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2016.10.017","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pretreatment and prophylaxis against nerve agent poisoning: Are undesirable behavioral side effects unavoidable?","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2016.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}